![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » REXAHN GETS EUROPEAN PATENT FOR ANXIETY DRUG
REXAHN GETS EUROPEAN PATENT FOR ANXIETY DRUG
Rexahn, a clinical stage biopharmaceutical company, announced that a European patent (EP 1206261) has been granted for the treatment of behavioural diseases with its leading CNS drug candidate, RX-10100. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=35344§ionid=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct